2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$4.55-$0.04 (-0.96%)
Price as of Sep 11, 2026 7:57 PM EDT- $298.7MMarket Cap
- 306.19%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$4.55-$0.04 (-0.96%)
PRLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.59 | ||
Change | -$0.08 (-1.71%) | ||
Open | $4.72 | ||
High | $4.75 | ||
Low | $4.56 | ||
Previous Close | $4.67 | ||
Volume | 520,527 | ||
30-Day Average Volume | 573,879 | ||
1-Week Change | -15.93% | ||
1-Month Change | -13.72% | ||
1-Year Change | 306.19% | ||
3-Year Change | 31.14% | ||
5-Year Change | -86.02% | ||
Fundamentals | |||
Shares Outstanding | 65.1M | ||
Total Assets | $189.4M | ||
Market Cap | $298.7M | ||
Enterprise Value | $272.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$13.9M | ||
Free Cash Flow | -$15.6M | ||
EBIT | -$13.9M | ||
EBITDA | -$13.6M | ||
Net Working Capital | $116.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 2 | ||
P/E | -33 | ||
PEG | 4 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue